Sonoma Biotherapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- February 06, 2020
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $40,000,000
Company Info
- Founders
- Jeffrey Bluestone, PhD
- Company Description
- Sonoma Biotherapeutics develops adoptive Treg therapies cell for autoimmune diseases.
- Market
- Autoimmune and degenerative diseases
- Location
- South San Francisco, California, USA
- Coinvestors
- ARCH Venture Partners, Lyell Immunopharma, Milky Way Ventures